{"id":462361,"date":"2013-03-07T10:25:58","date_gmt":"2013-03-07T04:55:58","guid":{"rendered":"http:\/\/stockviz.biz\/index.php\/?p=462361"},"modified":"2013-03-07T10:38:17","modified_gmt":"2013-03-07T05:08:17","slug":"analysis-sunpharma","status":"publish","type":"post","link":"https:\/\/stockviz.biz\/index.php\/2013\/03\/07\/analysis-sunpharma\/","title":{"rendered":"Analysis: SUNPHARMA"},"content":{"rendered":"<p>Today\u2019s pick is SUNPHARMA [stockquote]SUNPHARMA[\/stockquote]. The stock has been on an uptrend since the start of the year. After finding resistance at Rs. 550 for a couple of months, it started its up move.in June. It saw its 52 weeks high of Rs. 826 towards February end. Since then it is trending down. In the last three months, the stock moved <b>+11<strong>%<\/strong><\/b> Vs. -2% of the Nifty\u2019s.<\/p>\n<p><a title=\"SUNPHARMA Technical Analytis Chart\" href=\"http:\/\/stockviz.biz\/StockDive?TICKER=SUNPHARMA\"><img loading=\"lazy\" decoding=\"async\" style=\"margin: 10px;padding-left: 0px;padding-right: 0px;padding-top: 0px;border: 0px\" title=\"SUNPHARMA Technical Analytis Chart\" alt=\"SUNPHARMA Technical Analytis Chart\" src=\"http:\/\/portalvhds29z8xdrqhczq.blob.core.windows.net\/wordpress\/2013\/03\/STOCK.SUNPHARMA2013-03-07.png\" width=\"602\" height=\"482\" border=\"0\" \/><\/a><\/p>\n<p>Oscillator <a href=\"http:\/\/stockviz.biz\/index.php\/part-ix-relative-strength-index-rsi\/\">RSI<\/a> and <a href=\"http:\/\/stockviz.biz\/index.php\/technical-trading\/chande-momentum-oscillator\/\">CMO<\/a> are currently drawing back from the over-bought territory; a corrective move. The stock is currently trading in the middle of the <a href=\"http:\/\/stockviz.biz\/index.php\/2012\/07\/27\/bollinger-bands\/\">Bollinger band<\/a>s.<\/p>\n<p>The <a href=\"http:\/\/stockviz.biz\/index.php\/part-xi-moving-average-convergence-divergence-macd2\/\">MACD<\/a> line has just punctured the signal line in a bearish move accompanied with a downward moving histogram is signaling a short-term trend reversal. However, the Long-term <a href=\"http:\/\/stockviz.biz\/index.php\/technical-trading\/guppy-multiple-moving-averages\/\">GMMA<\/a> lines are expanding suggesting a bullish outlook for the long-term.<\/p>\n<p><a title=\"SUNPHARMA correlation chart\" href=\"http:\/\/stockviz.biz\/StockDive?TICKER=SUNPHARMA\"><img loading=\"lazy\" decoding=\"async\" style=\"margin: 10px;padding-left: 0px;padding-right: 0px;padding-top: 0px;border: 0px\" title=\"SUNPHARMA correlation chart\" alt=\"SUNPHARMA correlation chart\" src=\"http:\/\/portalvhds29z8xdrqhczq.blob.core.windows.net\/wordpress\/2013\/03\/cor.SUNPHARMA2013-03-07.png\" width=\"630\" height=\"210\" border=\"0\" \/><\/a><\/p>\n<p>SUNPHARMA\u2019s average <a href=\"http:\/\/stockviz.biz\/index.php\/tag\/correlation\/\">correlation<\/a> with the <a href=\"http:\/\/stockviz.biz\/Technicals.aspx?INDEX=NIFTY\">Nifty<\/a> is <b>0.41<\/b> which is <b>positive<\/b>. The scrip will be replicating movement of Nifty. [stockquote]NIFTYBEES[\/stockquote]<\/p>\n<p><a title=\"SUNPHARMA volatility chart\" href=\"http:\/\/stockviz.biz\/StockDive?TICKER=SUNPHARMA\"><img loading=\"lazy\" decoding=\"async\" style=\"margin: 10px;padding-left: 0px;padding-right: 0px;padding-top: 0px;border: 0px\" title=\"SUNPHARMA volatility chart\" alt=\"SUNPHARMA volatility chart\" src=\"http:\/\/portalvhds29z8xdrqhczq.blob.core.windows.net\/wordpress\/2013\/03\/Vol.SUNPHARMA2013-03-07.png\" width=\"630\" height=\"210\" border=\"0\" \/><\/a><\/p>\n<p>SUNPHARMA has a historical <a href=\"http:\/\/stockviz.biz\/index.php\/2012\/07\/17\/understanding-volatility-part-i\/\">volatility<\/a> in the range of 0.3 to 0.7. The scrip\u2019s volatility is currently in the lower end of the range.<\/p>\n<p>Given these technicals, we suggest a short-term<b> SELL. <\/b>A long-term <b>BUY<\/b> is suggested given the long-term trend-line in place. It is also suggested to have a relaxed <a href=\"http:\/\/stockviz.biz\/index.php\/2012\/10\/09\/setting-trailing-stop-loss-percentages\/\">trailing stop-losses<\/a> levels to book profits in case of a trend-reversal.<\/p>\n<h6 class=\"zemanta-related-title\" style=\"font-size: 1em\">Related articles<\/h6>\n<ul class=\"zemanta-article-ul zemanta-article-ul-image\" style=\"margin: 0px;padding: 0px;overflow: hidden\">\n<li class=\"zemanta-article-ul-li-image zemanta-article-ul-li\" style=\"margin: 2px 10px 10px 2px;padding: 0px;width: 84px;text-align: left;font-size: 11px;vertical-align: top;float: left\"><a style=\"padding: 2px;text-decoration: none\" href=\"http:\/\/www.biomedreports.com\/20130208122214\/sun-pharma-and-taro-announce-termination-of-proposed-transaction.html\" target=\"_blank\"><img decoding=\"async\" style=\"margin: 0px;padding: 0px;border: 0px currentColor;width: 80px\" alt=\"\" src=\"http:\/\/i.zemanta.com\/143976579_80_80.jpg\" \/><\/a><a style=\"padding: 5px 2px 0px;height: 80px;line-height: 12pt;overflow: hidden;text-decoration: none\" href=\"http:\/\/www.biomedreports.com\/20130208122214\/sun-pharma-and-taro-announce-termination-of-proposed-transaction.html\" target=\"_blank\">Sun Pharma and Taro Announce Termination of Proposed Transaction<\/a><\/li>\n<li class=\"zemanta-article-ul-li-image zemanta-article-ul-li\" style=\"margin: 2px 10px 10px 2px;padding: 0px;width: 84px;text-align: left;font-size: 11px;vertical-align: top;float: left\"><a style=\"padding: 2px;text-decoration: none\" href=\"http:\/\/www.easteconomist.com\/2013\/01\/sun-pharma-acquires-url-generic-business-from-takeda\/\" target=\"_blank\"><img decoding=\"async\" style=\"margin: 0px;padding: 0px;border: 0px currentColor;width: 80px\" alt=\"\" src=\"http:\/\/i.zemanta.com\/139474368_80_80.jpg\" \/><\/a><a style=\"padding: 5px 2px 0px;height: 80px;line-height: 12pt;overflow: hidden;text-decoration: none\" href=\"http:\/\/www.easteconomist.com\/2013\/01\/sun-pharma-acquires-url-generic-business-from-takeda\/\" target=\"_blank\">Sun Pharma Acquires URL Generic Business From Takeda<\/a><\/li>\n<li class=\"zemanta-article-ul-li-image zemanta-article-ul-li\" style=\"margin: 2px 10px 10px 2px;padding: 0px;width: 84px;text-align: left;font-size: 11px;vertical-align: top;float: left\"><a style=\"padding: 2px;text-decoration: none\" href=\"http:\/\/newsfromplanet.wordpress.com\/2013\/02\/08\/sun-pharmaceuticals-q3-net-profit-at-rs-881-cr\/\" target=\"_blank\"><img decoding=\"async\" style=\"margin: 0px;padding: 0px;border: 0px currentColor;width: 80px\" alt=\"\" src=\"http:\/\/i.zemanta.com\/144013089_80_80.jpg\" \/><\/a><a style=\"padding: 5px 2px 0px;height: 80px;line-height: 12pt;overflow: hidden;text-decoration: none\" href=\"http:\/\/newsfromplanet.wordpress.com\/2013\/02\/08\/sun-pharmaceuticals-q3-net-profit-at-rs-881-cr\/\" target=\"_blank\">Sun Pharmaceuticals Q3 net profit at Rs 881 cr<\/a><\/li>\n<\/ul>\n<div class=\"zemanta-pixie\" style=\"height: 15px;margin-top: 10px\"><img decoding=\"async\" class=\"zemanta-pixie-img\" style=\"border: currentColor;float: right\" alt=\"\" src=\"http:\/\/img.zemanta.com\/pixy.gif?x-id=d63836c2-c5fa-4866-9b1a-99022b9a4375\" \/><\/div>\n<div class=\"roundedCornerSmall\" style=\"height: 200px;padding-bottom: 0px;padding-left: 10px;width: 100%;padding-right: 0px;padding-top: 0px;border: grey 1px solid\">\n<div style=\"margin-top: 70px;float: left\"><a style=\"font-family: segoe ui;color: black;font-size: 18px;font-weight: 600\" href=\"http:\/\/stockviz.biz\/index.php\/2012\/11\/29\/the-stockviz-demat-account-2\/\">Open a StockViz Demat Account today!<\/a><\/div>\n<div style=\"float: right\"><a href=\"918026650232\"><img decoding=\"async\" style=\"border-width: 0px\" alt=\"call us qr code\" src=\"http:\/\/portalvhds29z8xdrqhczq.blob.core.windows.net\/web-static\/QR_CODE_DIRECT_CALL_634909979709728491.png\" \/><\/a><\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Today\u2019s pick is SUNPHARMA [stockquote]SUNPHARMA[\/stockquote]. The stock has been on an uptrend since the start of the year. After finding resistance at Rs. 550 for a couple of months, it started its up move.in June. It saw its 52 weeks high of Rs. 826 towards February end. Since then it is trending down. In the &hellip; <\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[9],"tags":[344,815],"class_list":["post-462361","post","type-post","status-publish","format-standard","hentry","category-your-money","tag-sunpharma","tag-technical-analysis","entry"],"_links":{"self":[{"href":"https:\/\/stockviz.biz\/index.php\/wp-json\/wp\/v2\/posts\/462361","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/stockviz.biz\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/stockviz.biz\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/stockviz.biz\/index.php\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/stockviz.biz\/index.php\/wp-json\/wp\/v2\/comments?post=462361"}],"version-history":[{"count":0,"href":"https:\/\/stockviz.biz\/index.php\/wp-json\/wp\/v2\/posts\/462361\/revisions"}],"wp:attachment":[{"href":"https:\/\/stockviz.biz\/index.php\/wp-json\/wp\/v2\/media?parent=462361"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/stockviz.biz\/index.php\/wp-json\/wp\/v2\/categories?post=462361"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/stockviz.biz\/index.php\/wp-json\/wp\/v2\/tags?post=462361"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}